Principal Financial Group Inc Haemonetics Corp Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 155,259 shares of HAE stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
155,259
Previous 192,692 19.43%
Holding current value
$13.9 Million
Previous $15.9 Million 21.72%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$72.45 - $91.58 $2.71 Million - $3.43 Million
-37,433 Reduced 19.43%
155,259 $12.5 Million
Q2 2024

Jul 29, 2024
SELL
$81.24 - $97.37 $1.54 Million - $1.85 Million
-18,985 Reduced 8.97%
192,692 $15.9 Million
Q1 2024

Apr 29, 2024
BUY
$71.24 - $85.35 $549,474 - $658,304
7,713 Added 3.78%
211,677 $18.1 Million
Q4 2023

Feb 07, 2024
BUY
$80.59 - $92.61 $371,036 - $426,376
4,604 Added 2.31%
203,964 $17.4 Million
Q3 2023

Nov 02, 2023
BUY
$82.56 - $93.49 $69,680 - $78,905
844 Added 0.43%
199,360 $17.9 Million
Q2 2023

Aug 07, 2023
SELL
$80.84 - $89.45 $721,739 - $798,609
-8,928 Reduced 4.3%
198,516 $16.9 Million
Q1 2023

May 09, 2023
SELL
$72.75 - $90.6 $99,012 - $123,306
-1,361 Reduced 0.65%
207,444 $17.2 Million
Q4 2022

Feb 09, 2023
SELL
$73.85 - $86.14 $337,199 - $393,315
-4,566 Reduced 2.14%
208,805 $16.4 Million
Q3 2022

Nov 09, 2022
SELL
$63.3 - $78.66 $1.49 Million - $1.85 Million
-23,527 Reduced 9.93%
213,371 $15.8 Million
Q2 2022

Aug 10, 2022
BUY
$49.27 - $66.08 $2.69 Million - $3.61 Million
54,583 Added 29.94%
236,898 $15.4 Million
Q1 2022

May 09, 2022
SELL
$43.77 - $63.22 $56,113 - $81,048
-1,282 Reduced 0.7%
182,315 $11.5 Million
Q4 2021

Feb 09, 2022
BUY
$49.55 - $74.59 $139,086 - $209,374
2,807 Added 1.55%
183,597 $9.74 Million
Q3 2021

Nov 09, 2021
BUY
$57.6 - $70.59 $18,374 - $22,518
319 Added 0.18%
180,790 $12.8 Million
Q2 2021

Aug 10, 2021
SELL
$51.81 - $118.56 $10.4 Million - $23.7 Million
-200,077 Reduced 52.58%
180,471 $12 Million
Q1 2021

May 10, 2021
BUY
$111.01 - $139.48 $25.2 Million - $31.7 Million
227,285 Added 148.3%
380,548 $42.2 Million
Q4 2020

Feb 08, 2021
SELL
$88.75 - $119.95 $46,238 - $62,493
-521 Reduced 0.34%
153,263 $18.2 Million
Q3 2020

Nov 06, 2020
SELL
$75.65 - $93.58 $377,720 - $467,244
-4,993 Reduced 3.14%
153,784 $13.4 Million
Q2 2020

Aug 05, 2020
BUY
$84.96 - $118.91 $78,757 - $110,229
927 Added 0.59%
158,777 $14.2 Million
Q1 2020

May 12, 2020
SELL
$74.34 - $121.82 $4.87 Million - $7.97 Million
-65,443 Reduced 29.31%
157,850 $15.7 Million
Q4 2019

Feb 05, 2020
SELL
$114.37 - $129.46 $178,874 - $202,475
-1,564 Reduced 0.7%
223,293 $25.7 Million
Q3 2019

Nov 13, 2019
SELL
$117.16 - $138.52 $521,010 - $615,998
-4,447 Reduced 1.94%
224,857 $28.4 Million
Q2 2019

Aug 12, 2019
SELL
$81.74 - $120.34 $625,964 - $921,563
-7,658 Reduced 3.23%
229,304 $27.6 Million
Q1 2019

May 10, 2019
SELL
$83.25 - $102.12 $80,669 - $98,954
-969 Reduced 0.41%
236,962 $20.7 Million
Q4 2018

Feb 14, 2019
SELL
$90.66 - $116.63 $2.03 Million - $2.61 Million
-22,347 Reduced 8.59%
237,931 $23.8 Million
Q3 2018

Nov 14, 2018
BUY
$89.96 - $114.58 $370,995 - $472,527
4,124 Added 1.61%
260,278 $29.8 Million
Q2 2018

Aug 13, 2018
SELL
$71.53 - $95.75 $13.6 Million - $18.2 Million
-190,294 Reduced 42.62%
256,154 $0
Q1 2018

May 14, 2018
BUY
$60.72 - $74.41 $975,952 - $1.2 Million
16,073 Added 3.73%
446,448 $32.7 Million
Q4 2017

Feb 13, 2018
SELL
$44.96 - $58.99 $28,684 - $37,635
-638 Reduced 0.15%
430,375 $25 Million
Q3 2017

Nov 02, 2017
BUY
$40.38 - $44.87 $17.4 Million - $19.3 Million
431,013
431,013 $19.3 Million

Others Institutions Holding HAE

# of Institutions
334
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email